Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
DGAT1-IN-3
Cat. No.:
OB0425LY-238
Appearance:
Solid
Purity:
99.92%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
DGAT1-IN-3 is a diacidase transporter protein 1 (DGAT1) inhibitor that interferes with the lipid synthesis pathway.
Synonyms:
939375-07-2; 2-Phenyl-5-trifluoromethyl-oxazole-4-carboxylic acid {6-[(2-methoxy-ethyl)-methyl-amino]-pyridin-3-yl}-amide; 2-Phenyl-5-trifluoromethyloxazole-4-carboxylic acid{6-[(2-Methoxyethyl)methylamino]pyridin-3-yl}amide; N-[6-[2-Methoxyethyl(methyl)amino]pyridin-3-yl]-2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carboxamide
CAS No.:
939375-07-2
Compound CID:
16757107
Formula:
C20H19F3N4O3
Formula Weight:
420.39
Specification
Target:
Acyltransferase
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
DGAT1-IN-3 is commonly used in lipid metabolism studies, especially in the study of obesity, type 2 diabetes and other diseases related to lipid metabolism.
